THTX - Theratechnologies Inc. (THTX) Q1 2024 Earnings Call Transcript

2024-04-10 10:47:02 ET

Theratechnologies Inc. (THTX)

Q1 2024 Earnings Conference Call

April 10, 2024 08:30 AM ET

Company Participants

Julie Schneiderman - Senior Director, Communications & Corporate Affairs

Paul Levesque - President & CEO

Philippe Dubuc - SVP & CFO

Christian Marsolais - SVP & Chief Medical Officer

John Leasure - Global Commercial Officer

Conference Call Participants

Carvey Leung - Cantor Fitzgerald

William Maughan - Canaccord Genuity

Presentation

Operator

Good morning, ladies and gentlemen, and thank you for standing by. Welcome to Theratechnologies First Quarter 2024 Earnings Call. We would like to remind everyone that all figures on this call are quoted in U.S. dollars. At this time, all participants are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session with analysts, instructions will be provided at that time for you to queue up for questions.

Following the analyst Q&A session, investors wishing to submit a question, may do so by clicking the Ask a Question link on the webcast platform. [Operator Instructions] I would like to remind everyone that this conference call is being recorded today, Wednesday, April 10, 2024 at 8:30 A.M. Eastern Time.

I will now turn the call over to Julie Schneiderman, Senior Director, Communications, and Corporate Affairs at Theratechnologies. Julie, please go ahead.

Julie Schneiderman

Thank you, operator, and good morning, everyone. On the call today will be Theratechnologies’ President and Chief Executive Officer, Mr. Paul Levesque; and Senior Vice President and Chief Financial Officer, Mr. Philippe Dubuc. During the Q&A session, we will be joined by Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer; and Mr. John Leasure, the company's Global Commercial Officer....

For further details see: